Recall
FDAHealthApril 17, 2025

Amneal Pharmaceuticals, LLC — Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal P

⚠️ Presence of Particulate Matter

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
April 17, 2025

Nationwide in the US

What's affected?

Product
Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)
UPC
0370121173533
Lot code
's:

Additional details

Lot #'s: AL240003, AL240004, Exp.: 01/31/2026

What should I do?

Recommended action

Class I recall. Voluntary: Firm initiated Quantity affected: 62 (12x100mL) bags.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.